1015 Capital Partners’s Pfizer PFE Stock Holding History
Bought
Maintained
Sold
Other funds holding PFE
1015 Capital Partners's PFE Position: Q3 2026 in Review
1015 Capital Partners sold out of Pfizer (PFE) in Q3 2026, closing a stake of 1,196 shares — an estimated $28.8K sold.
1015 Capital Partners first reported a position in PFE in Q4 2025 and held it in 3 quarters. The position peaked at $33.6K in Q1 2026. 2,918 funds tracked by Wall St. Rank hold PFE as of Q3 2026.
- 1015 Capital Partners reported no remaining Pfizer position as of Q3 2026 after selling out during the quarter.
- 1015 Capital Partners sold 1,196 Pfizer shares in Q3 2026, an estimated $28.8K.
- 1015 Capital Partners first reported a position in Pfizer in Q4 2025 and held it in 3 quarters.
- 1015 Capital Partners's Pfizer position peaked at $33.6K in Q1 2026.
- 2,918 funds tracked by Wall St. Rank held Pfizer as of Q3 2026.
Based on 1015 Capital Partners's 13F filing for Q3 2026, filed 16 Nov 2026.